BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 38296888)

  • 1. Unveiling the hidden role of disulfidptosis in kidney renal clear cell carcinoma: a prognostic signature for personalized treatment.
    Ye Y; Zeng S; Hu X
    Apoptosis; 2024 Jun; 29(5-6):693-708. PubMed ID: 38296888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-cell disulfidptosis regulator patterns guide intercellular communication of tumor microenvironment that contribute to kidney renal clear cell carcinoma progression and immunotherapy.
    Xu K; Li D; Qian J; Zhang Y; Zhang M; Zhou H; Hou X; Jiang J; Zhang Z; Sun H; Shi G; Dai H; Liu H
    Front Immunol; 2024; 15():1288240. PubMed ID: 38292868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a prognostic model based on different disulfidptosis related genes typing for kidney renal clear cell carcinoma.
    Feng Y; Wang W; Jiang S; Liu Y; Wang Y; Zhan X; Zhu H; Du G
    Front Pharmacol; 2024; 15():1343819. PubMed ID: 38549669
    [No Abstract]   [Full Text] [Related]  

  • 4. Crosstalk of disulfidptosis-related subtypes identifying a prognostic signature to improve prognosis and immunotherapy responses of clear cell renal cell carcinoma patients.
    Ren L; Liu J; Lin Q; He T; Huang G; Wang W; Zhan X; He Y; Huang B; Mao X
    BMC Genomics; 2024 Apr; 25(1):413. PubMed ID: 38671348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of disulfidptosis-related subtypes and development of a prognosis model based on stacking framework in renal clear cell carcinoma.
    Peng K; Wang N; Liu Q; Wang L; Duan X; Xie G; Li J; Ding D
    J Cancer Res Clin Oncol; 2023 Nov; 149(15):13793-13810. PubMed ID: 37530800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utilizing a novel model of PANoptosis-related genes for enhanced prognosis and immune status prediction in kidney renal clear cell carcinoma.
    Jiang Z; Wang J; Dao C; Zhu M; Li Y; Liu F; Zhao Y; Li J; Yang Y; Pan Z
    Apoptosis; 2024 Jun; 29(5-6):681-692. PubMed ID: 38281281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crosstalk of disulfidptosis-related subtypes, establishment of a prognostic signature and immune infiltration characteristics in bladder cancer based on a machine learning survival framework.
    Zhao S; Wang L; Ding W; Ye B; Cheng C; Shao J; Liu J; Zhou H
    Front Endocrinol (Lausanne); 2023; 14():1180404. PubMed ID: 37152941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Machine learning-driven prognostic analysis of cuproptosis and disulfidptosis-related lncRNAs in clear cell renal cell carcinoma: a step towards precision oncology.
    Chen R; Wu J; Che Y; Jiao Y; Sun H; Zhao Y; Chen P; Meng L; Zhao T
    Eur J Med Res; 2024 Mar; 29(1):176. PubMed ID: 38491523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disulfidptosis-Related LncRNA Signatures for Prognostic Prediction in Kidney Renal Clear Cell Carcinoma.
    Feng K; Zhou S; Sheng Y; Lu K; Li C; Liu W; Kong H; Liu H; Mu Y; Zhang L; Zhang Q; Wang J
    Clin Genitourin Cancer; 2024 Apr; 22(4):102095. PubMed ID: 38833825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioinformatics-based analysis of the relationship between disulfidptosis and prognosis and treatment response in pancreatic cancer.
    Xiong Y; Kong X; Mei H; Wang J; Zhou S
    Sci Rep; 2023 Dec; 13(1):22218. PubMed ID: 38097783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and validation of a novel signature based on macrophage marker genes for predicting prognosis and drug response in kidney renal clear cell carcinoma by integrated analysis of single cell and bulk RNA sequencing.
    Chen X; Zhang Z; Qin Z; Zhu X; Wang K; Kang L; Li C; Wang H
    Aging (Albany NY); 2024 Mar; 16(6):5676-5702. PubMed ID: 38517387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel risk signature based on liquid-liquid phase separation-related genes reveals prognostic and tumour microenvironmental features in clear cell renal cell carcinoma.
    Lu Q; Xi P; Xu S; Zhang Z; Gong B; Liu J; Zhu Q; Sun T; Zhu S; Chen R
    Aging (Albany NY); 2024 Mar; 16(7):6118-6134. PubMed ID: 38546385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression and prognostic value of TLR4 in kidney renal clear cell carcinoma.
    Hu Y; Gu Y; Song Y; Zhao Y; Wang J; Ma J; Sui F
    Mol Cell Probes; 2024 Jun; 75():101959. PubMed ID: 38579915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Troponin T1 in tumorigenesis and immune modulation: Insights into multiple cancers and kidney renal clear cell carcinoma.
    Zhang Q; Hao L; Wang F; Yu Q; Wu S; Han C
    J Cell Mol Med; 2024 Jun; 28(11):e18410. PubMed ID: 38853457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated Bioinformatics and Experimental Validation to Identify a Disulfidptosis-Related lncRNA Model for Prognostic Prediction in Papillary Renal Cell Carcinoma.
    Zhu Y; Jin X; Liu J
    Comb Chem High Throughput Screen; 2024 Apr; ():. PubMed ID: 38639274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigating the prognostic role of lncRNAs associated with disulfidptosis-related genes in clear cell renal cell carcinoma.
    Sun Z; Wang J; Fan Z; Yang Y; Meng X; Ma Z; Niu J; Guo R; Tran LJ; Zhang J; Jiang T; Liu Y; Yang Q; Ma B
    J Gene Med; 2024 Jan; 26(1):e3608. PubMed ID: 37897262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive analysis of disulfidptosis-related genes: a prognosis model construction and tumor microenvironment characterization in clear cell renal cell carcinoma.
    Yi B; Wei X; Liu D; Jing L; Xu S; Zhang M; Liang Z; Liu R; Zhang Z
    Aging (Albany NY); 2024 Feb; 16(4):3647-3673. PubMed ID: 38358909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disulfidptosis-related signature elucidates the prognostic, immunologic, and therapeutic characteristics in ovarian cancer.
    Cong Y; Cai G; Ding C; Zhang H; Chen J; Luo S; Liu J
    Front Genet; 2024; 15():1378907. PubMed ID: 38694875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disulfidptosis characterizes the tumor microenvironment and predicts immunotherapy sensitivity and prognosis in bladder cancer.
    Pan G; Xie H; Xia Y
    Heliyon; 2024 Feb; 10(3):e25573. PubMed ID: 38356551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment and validation of a novel peroxisome-related gene prognostic risk model in kidney clear cell carcinoma.
    Zhang J; Zhao Q; Huang H; Lin X
    BMC Urol; 2024 Jan; 24(1):26. PubMed ID: 38297313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.